| LFGCX | RGAHX | LFGCX / RGAHX | |
| Total Expense Ratio | 1.80 | 0.44 | 409% |
| Annual Report Gross Expense Ratio | 1.99 | 0.44 | 452% |
| Fund Existence | 7 years | 11 years | - |
| Gain YTD | 8.302 | 8.973 | 93% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1500 | 250 | 600% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 169M | 357B | 0% |
| Annual Yield % from dividends | 0.00 | 0.40 | - |
| Returns for 1 year | 15.17 | 5.67 | 268% |
| Returns for 3 years | 100.38 | 44.95 | 223% |
| Returns for 5 years | 31.83 | 17.59 | 181% |
| Returns for 10 years | N/A | 106.69 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AGGIX | 12.68 | 0.05 | +0.40% |
| American Century Focused Global Gr I | |||
| VDIPX | 35.66 | 0.12 | +0.34% |
| Vanguard Developed Markets Index Ins Pls | |||
| RBAIX | 29.90 | 0.06 | +0.20% |
| T. Rowe Price Balanced I | |||
| IVITX | 22.69 | N/A | N/A |
| VY® Invesco Growth and Income S2 | |||
| PHSZX | 51.53 | -0.80 | -1.53% |
| PGIM Jennison Health Sciences Z | |||